I agree that this site is using cookies. You can find further informations here.
X
Gonzalez-Angulo, Ana Maria
465  results:
Search for persons X
?
1

Oxidative Phosphorylation Is a Metabolic Vulnerability in C..:

Evans, Kurt W. ; Yuca, Erkan ; Scott, Stephen S....
Cancer Research.  81 (2021)  21 - p. 5572-5581 , 2021
Link: https://doi.org/10.1158/..
 
?
2

Phase II trial of AKT inhibitor MK-2206 in patients with ad..:

Xing, Yan ; Lin, Nancy U. ; Maurer, Matthew A....
Breast Cancer Research.  21 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
3

Selinexor (KPT-330) demonstrates anti-tumor efficacy in pre..:

Arango, Natalia Paez ; Yuca, Erkan ; Zhao, Ming...
Breast Cancer Research.  19 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
4

Correction: Ability to Generate Patient-Derived Breast Canc..:

McAuliffe, Priscilla F. ; Evans, Kurt W. ; Akcakanat, Argun...
PLOS ONE.  11 (2016)  3 - p. e0151121 , 2016
Link: https://doi.org/10.1371/..
 
?
5

The Association between EGFR and cMET Expression and Phosph..:

Chae, Young Kwang ; Gagliato, Debora de Melo ; Pai, Sachin Gopalkrishna...
PLOS ONE.  11 (2016)  4 - p. e0152585 , 2016
Link: https://doi.org/10.1371/..
 
?
6

Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/H..:

Trapé, Adriana Priscila ; Liu, Shuying ; Cortes, Andrea Carolina..
Journal of Cancer.  7 (2016)  8 - p. 947-956 , 2016
Link: https://doi.org/10.7150/..
 
?
7

Personalized Therapies for Cancer Treatment:

, In: Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies,
Nair, Lakshmy ; Gonzalez-Angulo, Ana Maria - p. 317-346 , 2015
Link: https://doi.org/10.1016/..
 
?
8

Ability to Generate Patient-Derived Breast Cancer Xenograft..:

McAuliffe, Priscilla F. ; Evans, Kurt W. ; Akcakanat, Argun...
PLOS ONE.  10 (2015)  9 - p. e0136851 , 2015
Link: https://doi.org/10.1371/..
 
?
9

List of Contributors:

, In: Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies,
Acevedo, Reinaldo ; Almagro, Juan C. ; Alsaadi, Manal... - p. vii-viii , 2015
Link: https://doi.org/10.1016/..
 
?
10

Residual tumor thickness at the tumor-normal tissue interfa..:

Zhou, Jane H. ; Rosen, Daniel ; Andreou, Andreas...
Annals of Diagnostic Pathology.  18 (2014)  5 - p. 266-270 , 2014
Link: https://doi.org/10.1016/..
 
?
11

Prospective evaluation of the conversion rate in the recept..:

de Dueñas, Eduardo Martínez ; Hernández, Ana Lluch ; Zotano, Ángel Guerrero...
Breast Cancer Research and Treatment.  143 (2014)  3 - p. 507-515 , 2014
Link: https://doi.org/10.1007/..
 
?
12

EZH2 expression correlates with locoregional recurrence aft..:

Debeb, Bisrat G ; Gong, Yun ; Atkinson, Rachel L...
Journal of Experimental & Clinical Cancer Research.  33 (2014)  1 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
13

Implications of Functional Proteomics in Breast Cancer:

Chae, Young Kwang ; Gonzalez-Angulo, Ana Maria
The Oncologist.  19 (2014)  4 - p. 328-335 , 2014
Link: https://doi.org/10.1634/..
 
?
14

HER2 testing: Current status and future directions:

Perez, Edith A. ; Cortés, Javier ; Gonzalez-Angulo, Ana Maria.
Cancer Treatment Reviews.  40 (2014)  2 - p. 276-284 , 2014
Link: https://doi.org/10.1016/..
 
?
15

Peroxiredoxin-1 protects estrogen receptor α from oxidative..:

O'Leary, Patrick C ; Terrile, Marta ; Bajor, Malgorzata...
Breast Cancer Research.  16 (2014)  4 - p. , 2014
Link: https://doi.org/10.1186/..
 
1-15